Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

Similar documents
AIDS in Africa. An Update. Basil Reekie

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Annex 2 A. Regional profile: West Africa

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

Scaling Up Nutrition Action for Africa

IMMUNIZATION VACCINES & EMERGENCIES

Progress has been made with respect to health conditions.

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Prioritizing Emergency Polio Eradication Activities

What is this document and who is it for?

Impact of Pathology Implementation Strategies in Sub Saharan Africa

Financing malaria control

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

Africa s slow fertility transition

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

Financing the HIV response in sub- Saharan Africa from domestic sources: moving beyond a normative approach

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Eligibility List 2018

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

STATUS REPORT ON MALARIA

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

The Challenge of Malaria

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

AFRICA. The continent of All challenges

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

Children in Africa. Key statistics on child survival, protection and development

UNAIDS 2013 AIDS by the numbers

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Ouagadougou Declaration

Comparative Analyses of Adolescent Nutrition Indicators

Aboubacar Kampo Chief of Health UNICEF Nigeria

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Tracking Progress in Scaling-Up Diagnosis and Treatment for Malaria

TFI Proceedings, Recommendations and implications for 2005

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Global Fund Results Fact Sheet Mid-2011

Update from GAVI Aurelia Nguyen

Expert Group Meeting on the Regional Report for the African Gender and Development Index

Health situation analysis in the African Region. Basic indicators 2006

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

Summary World Malaria Report 2010

IMMUNIZATION VACCINE DEVELOPMENT

Blood safety in Africa: Progress made during the last decade and major challenges for the Future

Global reductions in measles mortality and the risk of measles resurgence

Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa

Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS)

Ageing and mental health resources for older persons in the African region of the World Health Organization

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

ASLM Building laboratory capacity in Africa in a sustainable way

The Impact of Population Policies, Non-Governmental Organizations, and HIV/AIDS Policies on Fertility and HIV Prevalence in Sub-Saharan Africa 1

Global Fund Mid-2013 Results

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

Overview of WHO/UNICEF Immunization Coverage Estimates

Global Fund ARV Fact Sheet 1 st June, 2009

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Private Sector Opportunities to Support Family Planning and Access to Reproductive Health Services

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

African Gender and Development Index

Yellow fever Vaccine investment strategy

Common EQA Mistakes - A provider Perspective. Experience from East African Regional External Quality Assessment Scheme (EA-REQAS)

TT Procured by UNICEF

Global Polio Eradication Initiative

MONITORING THE IMPLEMENTATION OF THE HEALTH MILLENNIUM DEVELOPMENT GOALS. Report of the Secretariat. Executive Summary

Incorporating combination polypharmacy into national or provincial CVD control strategies: An African perspective

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

AFRICAN GENDER EQUALITY AND WOMEN S EMPOWERMENT SCORECARD

Plan of Presentation

CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans. CREOLE Study

CHILD SURVIVAL IN SUB-SAHARAN AFRICA TAKING STOCK

HPV Vaccine Lessons Learned & New Ways Forward

THE CARE WE PROMISE FACTS AND FIGURES 2017

Downloaded from:

Distr.: GENERAL. E/ECA/COE/31/8 AU/CAMEF/EXP/8(VII) 10 February Addis Ababa, Ethiopia March Original: ENGLISH

FACT SHEET SUB-SAHARAN AFRICA

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

Global summary of the AIDS epidemic, December 2007

Foreword. For further information please contact Dr Nivo Ramanandraibe at and Dr Ahmed E. Ogwell Ouma at

Barriers to Global TB Control. Carol D. Hamilton, MD, MHS Director, Scientific Affairs FHI 360 Professor of Medicine, Duke University

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

Expert Paper No. 2011/13

Race towards Sustainab. MD, PhD, FRSPH

511,000 (57% new cases) ~50,000 ~30,000

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

What is Treatment Optimisation (TO)

Medicines Regulation, Regulatory Harmonization, Global Initiatives. Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

Atlas of the African Health Statistics

Transcription:

Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA

Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently? Where does the money go and how is it used? Is the funding stable and appropriate to planning needs? Is the funding working? What does future funding look like?

Commitments of Global Fund, World Bank, US-PMI, and other countries participating in the DAC network support for malaria control between 2003 and 2009 Of note, 43 countries and more than 10 foundations or private organizations support the Global Fund channel; 18 countries or other multilaterals provide bilateral support for malaria. Other donors 7% 15% USAID and US-PMI 8% World Bank Global Fund 70% Commitments 2003 2009: total ~$4.6 billion over seven years.

Cumulative malaria funding commitments from the Global Fund, World Bank, and US PMI 2003 2009 for countries in and outside of sub Saharan Africa. As funding increased, the proportion going outside sub Saharan Africa decreased from 27% to 15%; consistent with estimates that sub Saharan Africa accounts for ~85% of the global malaria burden. 5000 4500 4000 3500 3000 2500 2000 1500 1000 500 0 Percent of funding going to countries outside Africa 27.3% 21.1% 18.3% 15.1% 19.3% 16.7% 15.1% 2003 2004 2005 2006 2007 2008 2009 Outside Africa Africa Source: Global Fund, World Bank and US PMI.

Average country Global Fund malaria cumulative expenditures through 2008 by category. Supportive Environment includes: Program management; Partnership development; Monitoring drug and insecticide resistance; and Other Systems Strengthening Components include: Human resources; PSM; Community systems; Information systems, Operations Research; M&E; and Other Systems Strengthening 14% Supportive Environment 13% Prevention 42% Prevention Components include: ITNs; Other vector control; Prevention in pregnancy; Behavior change communication; Other Treatment Treatment Components include: Drugs for treatment; Home-based care; Diagnosis; and Other 31% Source: Global Fund Enhanced Financial Reporting System. Represents ~$1.2 billion expended in 2008. Note: not all countries have completed reporting, but general compliance with reporting is good and 93% of expected reports were received by the end of December in 2009.

Cumulative funding commitments for the life of the grants from all external sources for 2003 2009 per person at risk (ppr) of malaria. There is an 80 fold difference between ppr funding levels in sub Saharan Africa Mauritania Mali Niger Chad Eritrea The Gambia Guinea Bissau Senegal Guinea Sierra Leone Burkina Faso Benin Togo Cote d'ivoire Ghana Nigeria Sudan Ethiopia Djibouti Liberia Central African Rep Cameroun Eq Guinea Uganda Somalia Total funding commitment 2003 2009 per population at risk of malaria Gabon Congo Congo, DRC Rwanda Burundi Tanzania Kenya Zanzibar > US$ 20.00/person US$ 10.00 19.99/person Angola Zambia Malawi US$ 5.00 9.99/person Zimbabwe Mozambique Madagascar US$ 2.00 4.99/person Namibia Botswana <US$ 2.00/person Swaziland South Africa Lesotho * Over the current life of all country malaria grants, the country per capita commitments ranged from US$50.93 (Sao Tome and Principe) to US$ 0.57 (Cote d Ivoire); no external grants were reported for Botswana, Cape Verde, or South Africa. Source: Data from the Global Fund, World Bank, US PMI, OECD, (as of December 2009).

Annual funding commitments per person at risk by Global Fund, World Bank, and US PMI, 12 countries, current USD, 2003 2009. Per-person annual commitment in US$

Total ITN procurement expenditures per person at risk between baseline and followup surveys and percentage point gain in coverage between these surveys, 9 countries. Percentage point gain in ITN household ownership Per person expenditures for ITNs

Estimated number of malaria deaths averted in children under age five due to changes in ITN and IPT coverage during 2000 2009, 12 countries. Three quarters of these estimated malaria deaths were averted since 2006

Global Fund approved requests for malaria control support over the life of the existing nine Rounds of funding. With the current 9 Rounds of approved grant requests, Global Fund resources will peak in 2010 at ~$ 1.3 billion US dollars in millions $1,400 $1,200 $1,000 $800 $600 $400 $200 Global Fund Rounds 9 8 7 6 5 4 3 2 1 $0 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Malaria Funding There is a costed plan: $ 5 to 6 billion/year External funding commitments have grown rapidly to ~$1.7 billion per year. There is a lag time between commitment disbursement expenditure delivery The money mostly comes from Global Fund (~70%), US-PMI, World Bank The money goes mostly to Africa (85%) and to prevention (1/3 rd ), treatment (1/3 rd ), program support (1/6 th ) and health system strengthening (1/6 th ) There is great variability in funding: highly variable perperson-at-risk and annually in countries Uncertainty in the future funding is very real